Format

Send to

Choose Destination
See comment in PubMed Commons below
Clin Pediatr (Phila). 2006 Nov;45(9):809-18.

Melatonin treatment in adolescents with delayed sleep phase syndrome.

Author information

1
Institute for Fatigue and Sleep Medicine, Sheba Medical Center, Tel Hashomer, Israel.

Abstract

This retrospective study describes the effects of long-term treatment with melatonin in 33 adolescents (age range, 10-18 years) with delayed sleep phase syndrome (DSPS). Patients were treated with oral melatonin, 3 to 5 mg/day for an average period of 6 months. During the treatment, sleep onset was advanced and sleep duration was longer. Treatment was also associated with a decrease in the proportion of patients reporting school difficulties. No adverse effects of melatonin were noted. This study indicates that long-term treatment with melatonin can be beneficial for adolescents with DSPS in terms of sleep-wake schedule and school performance.

PMID:
17041168
DOI:
10.1177/0009922806294218
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Atypon
    Loading ...
    Support Center